Notably, Retatrutide induced a robust rebound in the expression of several key oxidative enzymes that were profoundly suppressed by HFD, including Eci3 (8.51-fold), Cyp4a14 (5.44-fold), Cyp4a10 (5.05-fold), and Scd1 (4.61-fold)
Individual weight-loss is dependent on a number of factors but on average patients using these weight loss medications report an average loss of 1.5% of their body weight per week
If partially breastfeeding: If youre considering restarting GLP-1s and are still partially breastfeeding, thats a decision that really needs a conversation with your OB/GYN or your babys pediatrician
Our clinic recognizes that comparing yourself to others often ignores biological differences, genetic factors, and metabolic variations that make weight management significantly harder for some people regardless of effort or discipline
However, the medication's gastrointestinal side effects may indirectly increase risk through dehydration